Radiation-induced undifferentiated spindle cell sarcoma following high-dose-rate interstitial brachytherapy for tongue squamous cell carcinoma

被引:0
|
作者
Uchimoto, Yuka [1 ]
Shimamoto, Hiroaki [1 ,2 ,11 ]
Takeshita, Ami [1 ]
Oya, Kaori [3 ]
Kishino, Mitsunobu [3 ]
Fukuda, Yasuo [3 ]
Toyosawa, Satoru [4 ]
Oda, Michio [5 ]
Ogawa, Kazuhiko [2 ]
Kreiborg, Sven [6 ,7 ,8 ,9 ]
Mallya, Sanjay M. [10 ]
Murakami, Shumei [1 ,2 ]
机构
[1] Osaka Univ, Dept Oral & Maxillofacial Radiol, Grad Sch Dent, Osaka, Japan
[2] Osaka Univ, Dept Radiat Oncol, Grad Sch Med, Osaka, Japan
[3] Osaka Univ, Clin Lab, Dent Hosp, Osaka, Japan
[4] Osaka Univ, Dept Oral Pathol, Grad Sch Dent, Osaka, Japan
[5] Osaka Univ Hosp, Dept Med Technol, Osaka, Japan
[6] Univ Copenhagen, Fac Hlth & Med Sci, Sch Dent, Dept Pediat Dent & Clin Genet, Copenhagen, Denmark
[7] Univ Copenhagen, 3D Craniofacial Image Res Lab Sch Dent, Copenhagen, Denmark
[8] Rigshosp, Copenhagen Univ Hosp, Ctr Head & Orthoped, Copenhagen, Denmark
[9] Tech Univ Denmark, Dept Appl Math & Comp Sci, Copenhagen, Denmark
[10] UCLA, Sect Oral & Maxillofacial Radiol, Sch Dent, Los Angeles, CA USA
[11] Osaka Univ, Dept Oral & Maxillofacial Radiol, Grad Sch Dent, 1-8 Yamadaoka, Osaka, Suita 5650871, Japan
关键词
radiation-induced; sarcoma; brachytherapy; tongue; PSEUDOTUMOR; CANCER; HEAD;
D O I
10.5114/jcb.2022.116149
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High-dose-rate interstitial brachytherapy (HDR-ISBT) has recently come to be considered one of the most effective treatments for oral cancer. On the other hand, it is important to note that radiation therapy has some side effects. Especially, radiation-induced malignancy is probably the most serious complication affecting long-term survivors. We report a case of a radiation-induced undifferentiated spindle cell sarcoma that developed following HDR-ISBT for tongue squamous cell carcinoma (SCC). A 39-year-old woman with right tongue SCC underwent HDR-ISBT (60 Gy, 10 fractions, 8 days) treatment. Five years and one month later, a tumor had developed at the primary site. Surgery was performed for the tumor, which was histopathologically diagnosed as an undifferentiated spindle cell sarcoma. That was distinct from the squamous cell origin of the primary cancer. According to recently established criteria for radiation-induced malignancy, this case was classified as a radiation-induced sarcoma. A search of the literature revealed no previous report of radiation-induced malignancy following HDR-ISBT for tongue cancer.
引用
收藏
页码:268 / 272
页数:5
相关论文
共 50 条
  • [31] Management of Bartholin's gland carcinoma using high-dose-rate interstitial brachytherapy boost
    Thibault, Isabelle
    Lavallee, Marie-Claude
    Aubin, Sylviane
    Jain, Suneil
    Laflamme, Nathalie
    Vigneault, Eric
    BRACHYTHERAPY, 2013, 12 (05) : 500 - 507
  • [32] Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1–2 tongue tumours
    Zoltán Takácsi-Nagy
    Örs Ferenczi
    Tibor Major
    Hironori Akiyama
    Georgina Fröhlich
    Ferenc Oberna
    Mónika Révész
    Márton Poósz
    Csaba Polgár
    Strahlentherapie und Onkologie, 2022, 198 : 812 - 819
  • [33] Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients' health quality perception
    Bourdais, Remi
    Achkar, Samir
    Espenel, Sophie
    Bockel, Sophie
    Chauffert-Yvart, Laetitia
    de Mellis, Florence Ravet
    Minh-Hanh Ta
    Boukhelif, Wassila
    Durand-Labrunie, Jerome
    Burtin, Pascal
    Haie-Meder, Christine
    Deutsch, Eric
    Chargari, Cyrus
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (03) : 263 - 272
  • [34] Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes
    Laliscia, Concetta
    Gadducci, Angiolo
    Fabrini, Maria G.
    Barcellini, Amelia
    Guerrieri, Maria E.
    Parietti, Emanuela
    Ursino, Stefano
    Morganti, Riccardo
    Cafaro, Ines
    Paiar, Fabiola
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (11) : 697 - 701
  • [35] Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases
    Yoshida, Ken
    Yamazaki, Hideya
    Kotsuma, Tadayuki
    Akiyama, Hironori
    Takenaka, Tadashi
    Masui, Koji
    Yoshioka, Yasuo
    Uesugi, Yasuo
    Shimbo, Taiju
    Yoshikawa, Nobuhiko
    Yoshioka, Hiroto
    Arika, Takumi
    Tanaka, Eiichi
    Narumi, Yoshifumi
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (01) : 66 - 70
  • [36] Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy
    Chen, Jergin
    Pappas, Lisa
    Moeller, John H.
    Rankin, Jim
    Sharma, Pramod K.
    Bentz, Brandon G.
    Fang, L. Christine
    Hayes, John K.
    Shrieve, Dennis C.
    Hitchcock, Ying J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (04): : 362 - 369
  • [37] Small cell carcinoma of the prostate after high-dose-rate brachytherapy for low-risk prostatic adenocarcinoma
    Komiya, Akira
    Yasuda, Kenji
    Nozaki, Tetsuo
    Fujiuchi, Yasuyoshi
    Hayashi, Shin-Ichi
    Fuse, Hideki
    ONCOLOGY LETTERS, 2013, 5 (01) : 53 - 56
  • [38] HIGH-DOSE-RATE BRACHYTHERAPY FOR NON SMALL-CELL LUNG CARCINOMA: A RETROSPECTIVE STUDY OF 226 PATIENTS
    Gulcher, Maud Aumont-le
    Prevost, Bernard
    Sunyach, Marie Pierre
    Peiffert, Didier
    Maingon, Philippe
    Thomas, Laurence
    Williaume, Daniele
    Begue, Mickael
    Lerouge, Delphine
    Campion, Loic
    Mahe, Marc-Andre
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1112 - 1116
  • [39] HIGH-DOSE-RATE BRACHYTHERAPY HAS A CURATIVE POTENTIAL IN PATIENTS WITH INTRALUMINAL SQUAMOUS-CELL LUNG-CANCER
    SUTEDJA, G
    BARIS, G
    VANZANDWIJK, N
    POSTMUS, PE
    RESPIRATION, 1994, 61 (03) : 167 - 168
  • [40] Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy
    Sur, M
    Sur, R
    Cooper, K
    Levin, V
    Bizos, D
    Dubazana, N
    CANCER, 1996, 77 (11) : 2200 - 2205